Maryland
(State or other jurisdiction of incorporation) |
333-147363
(Commission File Number) |
20-5101287
(IRS Employer Identification No.) |
No. 588 Shiji Avenue, Xiangyang City, Shaanxi Province, The People’s Republic of China
(Address of principal executive offices) |
712046
(Zip Code) |
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 9.01 |
Financial Statements and Exhibits
|
(d) |
Exhibits |
BIOSTAR PHARMACEUTICALS, INC. | |||
Dated: August 18, 2009 |
By: |
/s/ Ronghua Wang | |
Name: Ronghua Wang | |||
Title: Chief Executive Officer |
|||